期刊文献+

甲状腺过氧化物酶及其抗体与甲状腺疾病 被引量:2

Thyroid peroxidase,its antibody and thyroid diseases
原文传递
导出
摘要 在自身免疫性甲状腺疾病(AITD)中,甲状腺过氧化物酶抗体(TPOAb)滴度有不同程度的升高,这对AITD的分类及预后有指导意义。最近研究表明,甲状腺组织甲状腺过氧化物酶(TPO)的异常表达或者血清中TPO含量的变化为甲状腺肿瘤的诊断提供了一种新的途径。另外,部分先天性甲状腺疾病的发生也与TPO基因突变相关。进一步研究TPO及TPOAb,有助于对甲状腺疾病病因的探讨并加深对甲状腺疾病诊断及治疗的认识。 Thyroid peroxidase antibody(TPOAb) titer increases differently in autoimmune thyroid disease(AITD). This will be helpful to identify the type of AITD and determine the prognosis. Abnormal expression of thyroid peroxidase(TPO) in thyroid or the change of TPO in serum can be used to distinguish the character of thyroid nodule. Besides ,TPO gene mutation leads to congenital thyroid diseases. Further research of TPO and TPOAb will deepen the cognition of the pathogenesis of thyroid diseases and will be helpful to the diagnosis and therapy of thyroid diseases.
出处 《国际内分泌代谢杂志》 2008年第1期62-65,共4页 International Journal of Endocrinology and Metabolism
关键词 甲状腺过氧化物酶 自身免疫性甲状腺疾病 甲状腺肿瘤 先天性甲状腺疾病 Thyroid peroxidase Autoimmane thyroid disease Thyroid tumor Congenital thyroid disease
  • 相关文献

参考文献20

  • 1Demers LM, Spencer CA. Laboratory medicine practice guidelines : laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol (Oxf) ,2003,58:138-140.
  • 2Ehrenshaft M, Mason RP. Protein radical formation on thyroid peroxidase during turnover as detected by immunospin trapping. Free Radic Biol Med ,2006,41:422-430.
  • 3Carle A, Laurberg P, Knudsen N,et al. Thyroid peroxidase and thyroglobulin auto-antibodies in patients with newly diagnosed overt hypothyroidism. Autoimmunity,2006,39:497-503.
  • 4Mazokopakis EE ,Papadakis JA ,Papadomanolaki MG. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto's thyroiditis. Thyroid ,2007,17:609- 612.
  • 5Rodriguez A J, Jicha GA, Steeves TD, et al. EEG changes in a patient with steroid-responsive encephalopathy associated with antibodies to thyroperoxidase( SREAT,Hashimoto's encephalopathy). J Clin Neurophysiol,2006 ,23 :371-373.
  • 6Guilhem I, Massart C,Poirier JY,et al. Differential evolution of thyroid peroxidase and thyrotropin receptor antibody in Graves' disease:thyroid peroxidase antibody activity reverts to pretreatment level after carbimazole withdrawal. Thyroid,2006,16 : 1041-1045.
  • 7陈威,满娜,李玉姝,单忠艳,滕卫平.血清甲状腺自身抗体、碘摄入量与Graves病发病及临床转归的关系[J].中华内科杂志,2006,45(2):95-99. 被引量:24
  • 8Grammaticos P, Vasiliou O,Papanastasiou E,et al. The clinical and laboratory findings in Graves' multinodular type disease. Hell J Nucl Med ,2006,9:53-59.
  • 9Goh SY, Ho SC, Seah LL, et al. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease and suggest ophthalmopathy is a multiantigenic disease. Clin Endocrinol (Oxf) ,2004,60:600-607.
  • 10Lai OF, Zaiden N, Goh SS, et al. Detection of thyroid peroxidase mRNA and protein in orbital tissue. Eur J Endocrinol,2006,155: 213-218.

二级参考文献14

  • 1Hutchings PR,Verma S,Phillips JM,et al.Both CD4(+) T cells and CD8(+) T cells are required for iodine accelerated thyroiditis in NOD mice.Cell Immunol,1999,192:113-121.
  • 2Lindberg O,Andersson LC,Lamberg BA.The impact of 25 years of iodine prophylaxis on the adult thyroid weight in Finland.J Endocrinol Invest,1989,12:789-793.
  • 3Michelangeli VP,Pawape G,Sinha A,et al.Clinical features and pathogenesis of thyrotoxicosis in adult Melanesians in Papua New Guinea.Clin Endocrinol (Oxf),2000,52:261-266.
  • 4Benker G,Vitti P,Kahaly G,et al.Response to methimazole in Graves' disease.The European Multicenter Study Group.Clin Endocrinol (Oxf),1995,43:257-263.
  • 5Wilson R,Mckillop JH,Thomson JA.The effect of pre-operative potassium iodide therapy on antibody production.Acta Endocrinol (Copenh),1990,123:531-534.
  • 6Paschke R,Vogg M,Winter J,et al.The influence of iodine on the intensity of the intrathyroidal autoimmune process in Graves' disease.Autoimmunity,1994,17:319-325.
  • 7Yang F,Teng W,Shan Z,et al.Epidemiological survey on the relationship between different iodine intakes and prevalence of hyperthyroidism.Eur J Endocrinol,2002,146:613-618.
  • 8Morgenthaler NG,Pampel I,Aust G,et al.Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.Horm Metab Res,1998,30:162-168.
  • 9Baloch Z,Carayon P,Conte-Devolx B,et al.Laboratory medicine practice guidelines.Laboratory support for the diagnosis and monitoring of thyroid disease.Thyroid,2003,13:3-126.
  • 10Kim WB,Chung HK,Park YJ,et al.The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.Thyroid,2000,10:579-586.

共引文献23

同被引文献16

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部